Update on DI call:
My brother initiated the call with DI this morning (25 minute call). He asked Dave if he could conference me into call, but DI preferred not. I will try to summarize: First, let me say that iwasadiver and bioinvestor4 (and others) have done a great job in summarizing (the DI message this morning) , i.e. "we need to chill out" and what we are seeing is no different on other message boards for pre-revenue biotech companies (similar issues, challenges and FUD). My brother said the call felt very positive. Dave indicated that they (NWBO) are working very hard, 24/7, to get us to the finish line. It has been more challenging/complicated (14 year trial) than they estimated especially with regards to estimating timelines, etc. The DL PR is still applicable -- other PRs will be kept to a minimum (e.g., Sawston, likely completed without PR confirmation). He did confirm that Duffy attended LL's presentation (how would he know that?) and when Duffy left NWBO, he went back to Merck to a nice (Director position) promotion. He confirmed there is a lot of interest (not just from Merck) in "succesful" and ongoing Keytruda combo trial being paid for and conducted by LL/UCLA. Dave did most of talking and displayed frustration with the 100s of (the same) questions and inquiries he receives "from 6am to 2am" daily. He said every time stock drops 5 cents the phones light up. Dave would not address list of specific questions everyone submitted, but again, his overall tone was quite positive. My brother gave it his best try. GLTA!!